Craft

WuXi AppTec

Stock Price

¥53.5

2024-10-29

Market Capitalization

¥147.9 B

2024-10-29

Revenue

¥43.1 B

FY, 2025

WuXi AppTec Summary

Company Summary

Overview
WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production. It offers services across biology, chemistry, testing, and manufacturing for small molecules, peptides, oligonucleotides, and biologics. The company serves the pharmaceutical, biotech, and medical device industries.
Type
Public
Status
Active
Founded
2000
HQ
Shanghai, CN | view all locations
Website
https://www.wuxiapptec.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Ge Li
  • Steve Yang
  • Minzhang Chen
  • Zhaohui Zhang

    Zhaohui Zhang, Executive Vice President, China Chief Operating Officer

    Operating MetricsView all

    Active Customers

    6K
    2.6%

    H1, 2023

    New Customers

    600
    7.7%

    H1, 2023

    Scientists and Researchers

    38K
    3.3%

    H1, 2023

    LocationsView all

    22 locations detected

    • Shanghai, Shanghai Shi HQ

      China

      288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area

    • Cranbury, NJ

      United States

      6 Cedarbrook Dr

    • Middletown, DE

      United States

      1091 Industrial Drive PO Box 930

    • Natick, MA

      United States

      22 Strathmore Road

    • Natick, MA

      United States

      3 Dean Rd 2nd floor

    • San Diego, CA

      United States

      6114 Nancy Ridge Dr

    and 16 others

    WuXi AppTec Financials

    Summary Financials

    Revenue (Q1, 2026)
    ¥12.3B
    Gross profit (Q1, 2026)
    ¥6.2B
    Net income (Q1, 2026)
    ¥4.7B
    Cash (Q1, 2026)
    ¥35.9B
    EBIT (Q1, 2026)
    ¥5.5B
    Enterprise value
    $120.4B

    Footer menu